ask="21.83"
ask_size="100"
average_daily_volume="72700"
bid="12.15"
bid_size="100"
book_value="3.13"
change="-0.11"
change_from_200_day_moving_average="2.59"
change_from_50_day_moving_average="0.24"
change_from_52_week_high="-1.18"
change_From_52_week_low="8.69"
change_in_percent="-0.53%"
close="20.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.70"
ebitda="-67.90M"
eps_estimate_current_year="-2.33"
eps_estimate_next_quarter="-0.58"
eps_estimate_next_year="-2.07"
ex_dividend_date="N/A"
float_shares="10188000"
high="20.90"
high_52_weeks="21.79"
last_trade_date="1/11/2017"
last_trade_price="20.61"
last_trade_size="100"
last_trade_time="3:59pm"
low="20.30"
low_52_weeks="11.92"
market_capitalization="519.56M"
moving_average_200_day="18.02"
moving_average_50_day="20.37"
name="Ascendis Pharma A/S - American "
notes="N/A"
one_year_target_price="29.67"
open="20.45"
pe_ratio="N/A"
peg_ratio="-0.37"
percent_change_from_200_day_moving_average="+14.36%"
percent_change_from_50_day_moving_average="+1.19%"
percent_change_from_52_week_high="-5.42%"
percent_change_from_52_week_low="+72.90%"
previous_close="20.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.62"
price_per_sales="88.91"
revenue="5.87M"
shares_outstanding="25209000"
short_ratio="8.24"
stock_exchange="NMS"
symbol="ASND"
volume="14433"
weeks_range_52="11.92 - 21.79"
